Ausgabe 11/2014
Inhalt (20 Artikel)
Simultaneous integrated boost intensity-modulated radiotherapy in esophageal carcinoma
Wei-Wei Yu, Zheng-Fei Zhu, Xiao-Long Fu, Kuai-Le Zhao, Jing-Fang Mao, Kai-Liang Wu, Huan-Jun Yang, Min Fan, Sen Zhao, James Welsh
Cisplatin- vs. oxaliplatin-based radiosensitizing chemotherapy for squamous cell carcinoma of the esophagus
K. Fakhrian, A. D. Ordu, B. Haller, J. Theisen, F. Lordick, V. Bišof, M. Molls, H. Geinitz
Intensity-modulated radiotherapy for stage IVA/IVB nasopharyngeal carcinoma
Lei Zeng, Yun-Ming Tian, Xue-Ming Sun, Ying Huang, Chun-Yan Chen, Fei Han, Shuai Liu, Mei Lan, Ying Guan, Xiao-Wu Deng, Tai-Xiang Lu
Early changes of parotid density and volume predict modifications at the end of therapy and intensity of acute xerostomia
Maria Luisa Belli, Elisa Scalco, Giuseppe Sanguineti, Claudio Fiorino, Sara Broggi, Nicola Dinapoli, Francesco Ricchetti, Vincenzo Valentini, Giovanna Rizzo, Giovanni Mauro Cattaneo
Postoperative [125I] seed brachytherapy in the treatment of acinic cell carcinoma of the parotid gland
Ming-hui Mao, Jian-Guo Zhang, Jie Zhang, Lei Zheng, Shu-ming Liu, Ming-wei Huang, Yan Shi
High-dose-rate interstitial brachytherapy in combination with androgen deprivation therapy for prostate cancer
Ken Yoshida, Hideya Yamazaki, Tadashi Takenaka, Tadayuki Kotsuma, Mineo Yoshida, Koji Masui, Yasuo Yoshioka, Yoshifumi Narumi, Toshitsugu Oka, Eiichi Tanaka
Evaluation of the prognostic role of tumor cell podoplanin expression in locally advanced squamous cell carcinoma of the head and neck
Stefan Huttenlocher, Nina D. Seibold, Maximilian P. Gebhard, Frank Noack, Christoph Thorns, Katrin Hasselbacher, Barbara Wollenberg, Steven E. Schild, Dirk Rades
High-resolution analysis of DNA copy number alterations in rectal cancer
Jérôme Doyen, Eric Letouzé, Laetitia Marisa, Aurélien de Reyniès, Gérard Milano, Marie-Christine Etienne-Grimaldi, Sylviane Olschwang, Jochen Gaedcke, Michael Ghadimi, Jean-Pierre Gérard
Mesenchymal stem cells are sensitive to treatment with kinase inhibitors and ionizing radiation
Nils H. Nicolay, Eva Sommer, Ramon Lopez Perez, Ute Wirkner, Tilman Bostel, Anthony D. Ho, Michael Lahn, Jürgen Debus, Rainer Saffrich, Peter E. Huber
Commissioning and first clinical application of mARC treatment
Yvonne Dzierma, Frank G Nuesken, Stephanie Kremp, Jan Palm, Norbert P Licht, Christian Rübe
Optimization by visualization of indices
Uwe Haverkamp, Darius Norkus, Jan Kriz, Mariam Müller Minai, Franz-Josef Prott, Hans Theodor Eich
In vivo dosimetry in intraoperative electron radiotherapy
Juan López-Tarjuelo, Ana Bouché-Babiloni, Virginia Morillo-Macías, Noelia de Marco-Blancas, Agustín Santos-Serra, Juan David Quirós-Higueras, Carlos Ferrer-Albiach
New possibilities for volumetric-modulated arc therapy using the AgilityTM 160-leaf multileaf collimator
Nadine Blümer, Christian Scherf, Janett Köhn, Eugen Kara, Britta Loutfi-Krauß, Detlef Imhoff, Claus Rödel, Ulla Ramm, Jörg Licher
G2-block after irradiation of cells with different p53 status
Friedo Zölzer, Ganesh Jagetia, Christian Streffer
Cutis verticis gyrata-like skin toxicity during treatment of melanoma patients with the BRAF inhibitor vemurafenib after whole-brain radiotherapy is a consequence of the development of multiple follicular cysts and milia
Nina Lang, Florian Sterzing, Alexander H. Enk, Jessica C. Hassel
Konventionell bestimmte Sicherheitssäume erfassen die Prostataloge nach Prostatektomie unvollständig
Martina Becker-Schiebe, Wolfgang Hoffmann
Strahlentherapie (4 Gy vs. 24 Gy) von Patienten mit indolentem Non-Hodgkin-Lymphom
Klaus Herfarth, Laila König
Prof. Dr. med. Thomas G. Wendt Direktor der Klinik für Strahlentherapie und Radioonkologie des Universitätsklinikums Jena zum 65. Geburtstag
Tilo Wiezorek, Gerhard G. Grabenbauer, Rolf Sauer